National uniformity would not pre-empt state tort laws under House FDA reform bill.
This article was originally published in The Tan Sheet
HOUSE FDA REFORM NATIONAL UNIFORMITY PROVISION DOES NOT PRE-EMPT STATE TORT LAW under an amendment to the drugs and biologics bill (HR 3199) sponsored by Rep. Richard Burr (R-N.C.). According to a revised draft bill released July 10, "nothing in the [national uniformity] section shall be construed to modify or otherwise affect any action or the liability of any person under the generally applicable tort law of any state."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC